HomeABCL • NASDAQ
add
AbCellera Biologics Inc
$3.61
Makalipas ang Oras ng Trabaho:(2.50%)+0.090
$3.70
Sarado: Peb 27, 8:00:00 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$3.59
Sakop ng araw
$3.36 - $3.62
Sakop ng taon
$1.89 - $6.52
Market cap
1.09B USD
Average na Volume
4.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 44.85M | 788.18% |
Gastos sa pagpapatakbo | 23.34M | 8,713.28% |
Net na kita | -8.94M | 73.85% |
Net profit margin | -19.94 | 97.06% |
Kita sa bawat share | -0.03 | 75.00% |
EBITDA | -22.46M | 13.76% |
Aktuwal na % ng binabayarang buwis | 54.13% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 533.83M | -14.67% |
Kabuuang asset | 1.36B | -0.26% |
Kabuuang sagutin | 390.05M | 28.11% |
Kabuuang equity | 966.90M | — |
Natitirang share | 303.16M | — |
Presyo para makapag-book | 1.11 | — |
Return on assets | -5.27% | — |
Return on capital | -6.45% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -8.94M | 73.85% |
Cash mula sa mga operasyon | -34.74M | -334.29% |
Cash mula sa pag-invest | 75.14M | 110.45% |
Cash mula sa financing | 4.12M | -0.65% |
Net change in cash | 44.80M | 50.92% |
Malayang cash flow | -6.97M | 90.38% |
Tungkol
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Itinatag
2012
Headquarters
Website
Mga Empleyado
562
